ID: ALA4589049

Max Phase: Preclinical

Molecular Formula: C17H25NO2

Molecular Weight: 275.39

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=C(CCCCCCc1cccc(O)c1)N1CCCC1

Standard InChI:  InChI=1S/C17H25NO2/c19-16-10-7-9-15(14-16)8-3-1-2-4-11-17(20)18-12-5-6-13-18/h7,9-10,14,19H,1-6,8,11-13H2

Standard InChI Key:  HSRXKLZLOHGCBU-UHFFFAOYSA-N

Associated Targets(non-human)

N-acylethanolamine-hydrolyzing acid amidase 372 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 275.39Molecular Weight (Monoisotopic): 275.1885AlogP: 3.51#Rotatable Bonds: 7
Polar Surface Area: 40.54Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.11CX Basic pKa: CX LogP: 3.58CX LogD: 3.58
Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.77Np Likeness Score: -0.19

References

1. Zhou P, Xiang L, Zhao D, Ren J, Qiu Y, Li Y..  (2019)  Synthesis, biological evaluation, and structure activity relationship (SAR) study of pyrrolidine amide derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors.,  10  (2): [PMID:30931090] [10.1039/C8MD00432C]

Source